Bo Norrving to Give Keynote Presentation at YoungStroke 2015

Bo Norving

Bo Norrving, immediate past President of the World Stroke Organization, will be the keynote presenter for YoungStroke 2015. The Lancet, the world’s leading neurology journal, credited his work for propelling the issue of stroke onto the global stage during its tribute last year.

Bo Norrving is professor in neurology at Lund University in Sweden. He was president of the World Stroke Organization from 2008 till 2012 and continues to serve the WSO as immediate past-president being the contact person from WSO to the WHO and the UN among several other tasks and engagements.

Bo Norrving is professor in neurology at Lund University, Sweden. He is corresponding author of the Swedish Aspirin Low-Dose Trial (SALT), the first trial to demonstrate the benefit of low dose aspirin therapy for stroke prevention.

He is a pioneer in cerebral hemodynamics by blood flow techniques, clinical syndromes of cerebellar stroke and lacunar infarcts, and silent small vessel disease, and he chairs the steering committee of SIFAP, the world’s largest study on stroke in the young.

He is a founding member if the International Stroke Genetics Consortium. He is Senior Consulting Editor for Stroke, and Associated Editor for Neuroepidemiology. He co-founded Riks-Stroke, the world’s 1 st national stroke registry. He chairs the section of cerebrovascular diseases of ICD-11 at WHO.

He contributes to the Stroke ABC Programme, which has provided basic stroke training to physicians covering hospital populations of >300 million people. He is a member of the program committee of the European Stroke Conference, the International Stroke Conference and the World Stroke Conference.

Bo Norrving was president of the World Stroke Organisation 2008-2012 and is currently past-president with a 4-year term till 2016.


Skip to toolbar